• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STAAR SURGICAL COMPANY IMPLANTABLE COLLAMER LENS (ICL); PHAKIC INTRAOCULAR LENS Back to Search Results
Model Number VTICMO12.6
Device Problems Misfocusing (1401); Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Macular Edema (1822); Inflammation (1932); Blurred Vision (2137); No Code Available (3191)
Event Date 07/18/2018
Event Type  Injury  
Manufacturer Narrative
This product is not marketed in the us.(b)(4).
 
Event Description
The reporter indicated that the surgeon implanted a 12.6 mm vticmo12.6, implantable collamer lens in the patient's left eye (os) on (b)(6) 2018.Lens was explanted on (b)(6) 2018 due to loss of bcva (post-op bcva 20/50) and cystoid macular edema.Antibiotics and anti-inflammatories were used to address inflammation.No infection occured.It was reported that the explant resolved the problem.Patient ok after edema adsorption.No plans to implant an icl lens.
 
Manufacturer Narrative
Additional data: device evaluation: the lens was returned dry, in a micro-centrifuge vial.There was clear surgical residue on the product and lens surface.Visual inspection found no visible damage to the lens.Corrected data: work order search: no similar complaint type events reported for units within the same lot - is added to initial mdr.(b)(4).
 
Manufacturer Narrative
Corrected data: the reporter indicated that the surgeon implanted a 12.6 mm vticmo12.6, -15/+0.5/038 (sphere/cylinder/axis), implantable collamer lens in the patient's left eye (os) on (b)(6) 2017.Lens was explanted on (b)(6) 2018 due to loss of bcva (post-op bcva 20/50) and cystoid macular edema.Antibiotics and anti-inflammatories were used to address inflammation.No infection occurred.It was reported that the explant resolved the problem.Patient ok after edema adsorption.No plans to implant an icl lens.(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
IMPLANTABLE COLLAMER LENS (ICL)
Type of Device
PHAKIC INTRAOCULAR LENS
Manufacturer (Section D)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer (Section G)
STAAR SURGICAL COMPANY
1911 walker avenue
monrovia CA 91016
Manufacturer Contact
cynthia thai
1911 walker avenue
monrovia, CA 91016
MDR Report Key7890073
MDR Text Key120745216
Report Number2023826-2018-01388
Device Sequence Number1
Product Code MTA
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
N/A
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type distributor,foreign,health pr
Reporter Occupation Physician
Type of Report Initial,Followup,Followup
Report Date 08/28/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/30/2019
Device Model NumberVTICMO12.6
Device Catalogue NumberN/A
Device Lot NumberN/A
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer10/05/2018
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 08/28/2018
Initial Date FDA Received09/19/2018
Supplement Dates Manufacturer Received10/19/2018
12/04/2018
Supplement Dates FDA Received11/12/2018
12/06/2018
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured07/14/2016
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age31 YR
-
-